SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-068794
Filing Date
2023-12-07
Accepted
2023-12-07 16:05:14
Documents
13
Period of Report
2023-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20231201.htm   iXBRL 8-K 42085
  Complete submission text file 0000950170-23-068794.txt   197074

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asmb-20231201_lab.xml EX-101.LAB 21019
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asmb-20231201.xsd EX-101.SCH 2918
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asmb-20231201_pre.xml EX-101.PRE 13625
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asmb-20231201_def.xml EX-101.DEF 13503
7 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20231201_htm.xml XML 6189
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 231472371
SIC: 2834 Pharmaceutical Preparations